Intraventricular α-interferon in subacute sclerosing panencephalitis

@article{Cianchetti1998IntraventricularI,
  title={Intraventricular α-interferon in subacute sclerosing panencephalitis},
  author={C. Cianchetti and M. Marrosu and F. Muntoni and A. Fratta and A. Zuddas},
  journal={Neurology},
  year={1998},
  volume={50},
  pages={315 - 315}
}
  • C. Cianchetti, M. Marrosu, +2 authors A. Zuddas
  • Published 1998
  • Medicine
  • Neurology
  • To the Editor: Anlar et al.1 reported the favorable effect of intraventricular (IVC) human α-interferon (IFN) plus isoprinosine in subacute sclerosing panencephalitis (SSPE). Theirα-IFN treatment regimen consisted of a 6-week course, 5-day/week administration, with a total of 30 × 106 U/m2 (5× 106 U/m2 each week); in some cases (not specified how many), the course was repeated at 2- to 6-month intervals, up to 6 times. We wonder whether better results could be obtained by a more prolonged… CONTINUE READING

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 10 REFERENCES
    Combined oral isoprinosineintraventricular a-interferon therapy for subacute sclerosing panencephalitis
    • 1993
    Detection of measles virus
    • 1998
    Detection of measles virus RNA
      Long-term follow-up of patients with subacute sclerosing panencephalitis treated with intraventricular a-interferon
      • 1997